Back to Compound Explorer

Alisol B 23-Acetate

Preliminary

Mechanism of Action

Inhibits hepatic lipid synthesis via HMG-CoA reductase inhibition; activates FXR (farnesoid X receptor) to regulate bile acid and cholesterol metabolism; induces hepatocyte autophagy to clear lipid droplets; anti-inflammatory via NF-κB pathway suppression

Research Notes

Alisol B 23-acetate demonstrates potent hypolipidemic effects in high-fat diet mouse models, reducing hepatic steatosis markers (ALT, AST, TG, TC) and improving liver histology. FXR agonist activity confirmed in vitro. Preliminary evidence for NAFLD management; human clinical trial data limited but growing in Chinese literature.

Found In 1 Herb

3D Molecular Structure

Protostane-type tetracyclic triterpenoid
Drag to rotate · Click atoms to explore

Alisol B 23-Acetate

Protostane-type tetracyclic triterpenoidModified terpenes with diverse biological activities

Representative pattern: C₁₀H₁₆O

Atoms
Carbon
Oxygen
Hydrogen

Related Compounds (Protostane-type tetracyclic triterpenoid)

Live Research

Open on PubMed

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.